HROW
HARROW, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$27.68
+1.47%Leverage
- Debt / equity
- 19.79x
- Net debt / equity
- 14.27x
- Debt / assets
- 0.72x
- Debt / EBITDA
- 26.88x
- Net debt / EBITDA
- 19.38x
Liquidity & coverage
- Current ratio
- 2.24x
- Quick ratio
- 2.08x
- Cash ratio
- 0.82x
- Interest coverage
- 0.25x
- EBITDA / interest
- 0.49x
- Working capital
- $127.1M
Cash & dividend
- FCF / debt
- 0.02x
- Cash flow / debt
- 0.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026